Equity · Healthcare
ENOV
NYSEEnovis (ENOV)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.
- Market cap
- 1.6B USD
- Revenue, year to Dec 2025
- 2.2B USD
- EPS, diluted, year to Dec 2025
- −20.75 USD
- 52-week range
- 20.03 USD – 36 USD
- Avg volume
- 264.8K
as of Jul 17, 2026
Have Enovis (ENOV) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Enovis insiders reported 4 open-market purchases and no sales (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest reported trade 4 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Sep 2026 | Engert OliverChief Administrative Officer | Buy | 2,660 | 50K USD |
| 04 Sep 2026 | McDonald DamienChief Executive Officer | Buy | 13,035 | 250K USD |
| 03 Sep 2026 | Engert OliverChief Administrative Officer | Buy | 5,140 | 100K USD |
| 02 Sep 2026 | Engert OliverChief Administrative Officer | Buy | 2,458 | 50K USD |
| Bought | 4 open-market purchases | 23,293 | $450K |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 30 Sep 2026 | Ortiz ChristineDirector | Award | 958 |
Which funds hold Enovis (ENOV)?
8 of the 45 institutional funds we track reported a Enovis position for the quarter ended 30 Jun 2026 — a combined 47.8M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Millennium Management | Added | 803,315 | 16.6M USD | +27.6% |
| AQR Capital Management | Added | 590,647 | 12.2M USD | +108.0% |
| Man Group | Held (±25%) | 420,821 | 8.7M USD | −20.4% |
| Marshall Wace | Held (±25%) | 294,445 | 6.1M USD | +12.8% |
| D. E. Shaw & Co. | Held (±25%) | 83,796 | 1.7M USD | −17.9% |
| Bridgewater Associates | Added | 77,088 | 1.6M USD | +50.5% |
| Tudor Investment Corp | Trimmed | 25,167 | 521K USD | −83.1% |
| GAMCO Investors | Held (±25%) | 14,243 | 295K USD | +1.3% |
| Balyasny Asset Management | Exited | |||
| Citadel Advisors | Exited |
What has been filed or recorded for Enovis (ENOV)?
The filings we hold for Enovis, newest first: 3 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 89 shares | 2K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 332 shares | 6K USD notional · 0.001% of shares out |
| 02 Oct 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.06 USD | |
| 02 Oct 2026 | Financials | Total assets | 3.7B USD | at period end |
| 02 Oct 2026 | Financials | Total equity | 1.5B USD | at period end |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 2,032 shares | 38K USD notional · 0.004% of shares out |
| 03 Jul 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.02 USD | |
| 03 Apr 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.15 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −20.75 USD | |
| 31 Dec 2025 | Financials | Revenue | 2.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −1.2B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −20.75 USD | fiscal year |
| 03 Oct 2025 | Quarterly earnings | Q3 2025 reported | EPS −9.99 USD | |
| 04 Jul 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.64 USD | |
| 04 Apr 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.98 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −14.93 USD |
What do people ask about Enovis (ENOV)?
What is Enovis’ market cap?1.6B
Enovis is worth 1.6B USD by market value as of 17 Jul 2026, which is the share price times the shares on issue from its SEC filings.
What is Enovis’ revenue?2.2B
Enovis reported revenue of 2.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Enovis insiders bought or sold shares recently?4 purchases
In the 90 days to 10 Nov 2026, Enovis insiders reported 4 open-market purchases and no sales (SEC Form 4). A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own Enovis?8 of 45
8 of the 45 funds we track reported a Enovis position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Millennium Management, AQR Capital Management and Man Group. See Funds
When did Enovis last report earnings?0.06
Enovis last reported earnings on 2 Oct 2026 for Q3 2026, with EPS of 0.06 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 02 Oct 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings